Inhaled fentanyl citrate improves exercise endurance during high-intensity constant work rate cycle exercise in chronic obstructive pulmonary disease

Journal of Pain and Symptom Management

Volumn 43, Issue 4, 2012, Pages 706-719

  Jensen, Dennis ^a,b   Alsuhail, Abdullah ^b   Viola, Raymond ^b   Dudgeon, Deborah J ^b   Webb, Katherine A ^b   O'Donnell, Denis E ^b  

^a MCGILL UNIVERSITY   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

COPD; Dyspnea; exercise; fentanyl citrate; nebulized; opioids; symptom management

Indexed keywords

FENTANYL CITRATE;

AGED; ARTICLE; BREATHING MECHANICS; BREATHING PATTERN; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; CYCLING; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DYSPNEA; ENDURANCE; EXERCISE INTENSITY; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG FUNCTION TEST; LUNG GAS EXCHANGE; LUNG VENTILATION; MALE; NEBULIZATION; PLETHYSMOGRAPHY; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; SPIROMETRY; SYMPTOMATOLOGY;

ADMINISTRATION, INHALATION; AGED; ANALGESICS, OPIOID; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; EXERCISE TOLERANCE; FEMALE; FENTANYL; HUMANS; MALE; PHYSICAL EXERTION; PLACEBO EFFECT; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TREATMENT OUTCOME;

EID: 84859213653     PISSN: 08853924     EISSN: 18736513     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2011.05.007     Document Type: Article

References (74)

1. P.W. Jones Health status measurement in chronic obstructive pulmonary disease Thorax 56 2001 880 887 (Pubitemid 32999838)
2. D.E. O'Donnell, S. Aaron, and J. Bourbeau Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update Can Respir J 14 2007 5B 32B (Pubitemid 350090390)
3. S.J. Brown, S.F. Eichner, and J.R. Jones Nebulized morphine for relief of dyspnea due to chronic lung disease Ann Pharmacother 39 2005 1088 1092 (Pubitemid 40695977)
4. P.A. Foral, M.A. Malesker, G. Huerta, and D.E. Hilleman Nebulized opioids use in COPD Chest 125 2004 691 694 (Pubitemid 38223651)
5. B. Varkey Opioids for palliation of refractory dyspnea in chronic obstructive pulmonary disease Curr Opin Pulm Med 16 2010 150 154
6. A.O. Harris-Eze, G. Sridhar, and R.E. Clemens Low-dose nebulized morphine does not improve exercise in interstitial lung disease Am J Respir Crit Care Med 152 1995 1940 1945
7. I.H. Young, E. Daviska, and V.A. Keena Effect of low dose nebulised morphine on exercise endurance in patients with chronic lung disease Thorax 44 1989 387 390 (Pubitemid 19143946)
8. A.R. Masood, J.W. Reed, and S.H.L. Thomas Lack of effect of inhaled morphine on exercise-induced breathlessness in chronic obstructive pulmonary disease Thorax 50 1995 629 634
9. W. Beauford, T.T. Saylor, D.W. Stansbury, K. Avalos, and R.W. Light Effects of nebulized morphine sulphate on the exercise tolerance of the ventilatory limited COPD patient Chest 104 1993 175 178 (Pubitemid 23204553)
10. R. Leung, P. Hill, and J. Burdon Effect of inhaled morphine on the development of breathlessness during exercise in patients with chronic lung disease Thorax 51 1996 596 600 (Pubitemid 26226513)
11. D. Jankelson, K. Hosseini, L.E. Mather, J.P. Seale, and I.H. Young Lack of effect of high doses of inhaled morphine on exercise endurance in chronic obstructive pulmonary disease Eur Respir J 10 1997 2270 2274 (Pubitemid 27479548)
12. A.L. Jennings, A.N. Davis, J.P.T. Higgins, J. Anzures-Cabrera, and K.E. Broadley Opioids for the palliation of breathlessness in terminal illness Cochrane Database Syst Rev 4 2001 CD002066
13. T. Oga, K. Nishimura, and M. Tsukino The effects of oxitropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease. A comparison of three different exercise tests Am J Respir Crit Care Med 161 2000 1897 1901 (Pubitemid 30418126)
14. P.J. Coyne, R. Viswanathan, and T.J. Smith Nebulized fentanyl citrate improves patients' perception of breathing, respiratory rate, and oxygen saturation in dyspnea J Pain Symptom Manage 23 2002 157 160 (Pubitemid 34158649)
15. R.W. Light, J.R. Muro, and S.I. Sata Effects of oral morphine on breathlessness and exercise tolerance in patients with chronic obstructive pulmonary disease Am Rev Respir Dis 139 1989 126 133 (Pubitemid 19030433)
16. D.A. Mahler, J.A. Murray, and L.A. Waterman Endogenous opioids modify dyspnea during treadmill exercise in patients with COPD Eur Respir J 33 2009 771 777
17. S.E. Zebraski, S.M. Kochenash, and R.B. Raffa Lung opioid receptors: pharmacology and possible target for nebulized morphine in dyspnea Life Sci 66 2000 2221 2231 (Pubitemid 30256621)
18. M. Krajnik, M. Schafer, and P. Sobanksi Local pulmonary opioid network in patients with lung cancer: a putative modulator of respiratory function Pharmacol Rep 62 2010 139 149
19. M. Krajnik, M. Schafer, and P. Sobanksi Enkephalin, its precursor, processing enzymes, and receptor as part of a local opioid network throughout the respiratory system of lung cancer patients Hum Pathol 41 2010 632 642
20. M.G. Belvisi, and D.J. Hele Cough sensors. III. Opioid and cannabinoid receptors on vagal sensory nerves Handb Exp Pharmacol 187 2009 63 76
21. M.G. Belvisi, C.D. Stretton, and G.M. Verleden Inhibition of cholinergic neurotransmission in human airways by opioids J Appl Physiol 72 1992 1096 1100
22. H.J. Patel, P. Venkatesan, and J. Halfpenny Modulation of acetylcholine release from parasympathetic nerves innervating guinea-pig and human trachea by endomorphin-1 and -2 Eur J Pharmacol 374 1999 21 24 (Pubitemid 29296721)
23. I.G. Johansson, N. Grundstrom, and R.G. Andersson Both the cholinergic and non-cholinergic components of airway excitation are inhibited by morphine in the guinea-pig Acta Physiol Scand 135 1989 411 415 (Pubitemid 19069135)
24. M.G. Belvisi, C.D. Stretton, and P.J. Barnes Modulation of cholinergic neurotransmission in guinea-pig airways by opioids Br J Pharmacol 100 1990 131 137 (Pubitemid 20161442)
25. J.L. Pype, L.J. Dupont, M.G. Demedts, and G.M. Verleden Opioids modulate the cholinergic contraction but not the nonadrenergic relaxation in guinea-pig airways in vitro Eur Respir J 9 1996 2280 2285 (Pubitemid 26366654)
26. L. Zappi, F. Nicosia, D. Rocchi, P. Song, and K. Rehder Opioid agonists modulate release of neurotransmitters in bovine trachealis muscle Anesthesiology 83 1995 543 551
27. L. Zappi, P. Song, S. Nicosia, F. Nicosia, and K. Rehder Inhibition of airway constriction by opioids is different down the isolated bovine airway Anesthesiology 86 1997 1334 1341 (Pubitemid 27262311)
28. Y. Yu, Y. Cui, and W. Wang Endomorphin1 and endomorphin2, endogenous potent inhibitors of electrical field stimulation (EFS)-induced cholinergic contractions of rat isolated bronchus Peptides 27 2006 1846 1851 (Pubitemid 43866276)
29. E. Tagaya, J. Tamaoki, A. Chiyotani, and K. Konno Stimulation of opioid mu-receptors potentiates beta adrenoceptor-mediated relaxation of canine airway smooth muscle J Pharmacol Exp Ther 275 1995 1288 1292
30. N. Frossard, and P.J. Barnes Mu-opioid receptors modulate non-cholinergic constrictor nerves in guinea-pig airways Eur J Pharmacol 141 1987 519 522 (Pubitemid 17150154)
31. M.G. Belvisi, K.F. Chung, D.M. Jackson, and P.J. Barnes Opioid modulation of non-cholinergic neural bronchoconstriction in guinea-pig in vivo Br J Pharmacol 95 1988 413 418
32. H.N. Sapru, R.N. Willette, and A.J. Krieger Stimulation of pulmonary J receptors by an encephalin-analog J Pharmacol Exp Ther 217 1981 228 234
33. R.N. Willette, and H.N. Sapru Peripheral versus central cardiorespiratory effects of morphine Neuropharmacology 21 1982 1019 1026 (Pubitemid 12001298)
34. R.N. Willette, and H.N. Sapru Pulmonary opiate receptor activation evokes a cardiorespiratory reflex Eur J Pharmacol 78 1982 61 70 (Pubitemid 12187789)
35. R.N. Willette, P. Gatti, S.B. Gertner, and H.N. Sapru Pulmonary vagal afferent stimulants in the conscious rat: opioids and phenyldiguanide Pharmacol Biochem Behav 17 1982 19 23 (Pubitemid 12040732)
36. 3]U-69,593 to airway and pulmonary tissues of normal and sensitized rats Peptides 18 1997 1603 1608 (Pubitemid 28133004)
37. P.J. Cabot, P.R. Dodd, T. Cramond, and M.T. Smith Characterization of non-conventional opioid binding sites in rat and human lung Eur J Pharmacol 268 1994 247 255
38. D.A. Mahler, D.H. Weinberg, C.K. Wells, and A.R. Feinstein The measurement of dyspnea: contents, interobserver agreement, and physiologic correlates of two new clinical indexes Chest 85 1984 751 758 (Pubitemid 14121920)
39. J.K. Stoller, R. Ferranti, and A.R. Feinstein Further specification and evaluation of a new clinical index for dyspnea Am Rev Respir Dis 135 1986 1129 1134 (Pubitemid 17216885)
40. C.R. McGavin, M. Artvinli, H. Naoe, and G.J.R. McHardy Dyspnoea, disability, and distance walked: comparison of estimates of exercise performance in respiratory disease Br Med J 2 1978 241 243 (Pubitemid 8382018)
41. K.F. Rabe, S. Hurd, and A. Anzueto Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary Am J Respir Crit Care Med 176 2007 532 555 (Pubitemid 47403272)
42. P.W. Jones, F.H. Quirk, C.M. Baveystock, and P. Littlejohns A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire Am Rev Respir Dis 145 1992 1321 1327
43. A.S. Zigmond, and R.P. Snaith The Hospital Anxiety and Depression Scale Acta Psychiatr Scand 67 1983 361 370 (Pubitemid 13098606)
44. American Thoracic Society and American College of Chest Physicians ATS/ACCP statement on cardiopulmonary exercise testing Am J Respir Crit Care Med 167 2003 211 277
45. J. Roca, B.J. Whipp, and A.G.N. Agusti Clinical exercise testing with reference to lung diseases: indications, standardization and interpretation strategies. ERS Task Force on Standardization of Clinical Exercise Testing Eur Respir J 10 1997 2662 2689 (Pubitemid 28048650)
46. D.E. O'Donnell, M. Lam, and K.A. Webb Measurement of symptoms, lung hyperinflation and endurance during exercise in chronic obstructive pulmonary disease Am J Respir Crit Care Med 158 1998 1557 1565
47. D.E. O'Donnell, S.M. Revill, and K.A. Webb Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease Am J Respir Crit Care Med 164 2001 770 777 (Pubitemid 32881912)
48. G.A. Borg Psychophysical bases of perceived exertion Med Sci Sports Exerc 14 1982 377 381 (Pubitemid 13215050)
49. M.R. Miller, R. Crapo, and J. Hankinson General considerations for lung function testing Eur Respir J 26 2005 153 161 (Pubitemid 40945944)
50. M.R. Miller, J. Hankinson, and V. Brusasco Standardisation of spirometry Eur Respir J 26 2005 319 338 (Pubitemid 41079078)
51. N. MacIntyre, R.O. Crapo, and G. Viegi Standardisation of the single-breath determination of carbon monoxide uptake in the lung Eur Respir J 26 2005 720 735 (Pubitemid 41448672)
52. American Thoracic Society/European Respiratory Society ATS/ERS Statement on respiratory muscle testing Am J Respir Crit Care Med 166 2002 518 624
53. J. Wanger, J.L. Clausen, and A. Coates Standardisation of the measurement of lung volumes Eur Respir J 26 2005 511 522 (Pubitemid 41264217)
54. J.F. Morris, A. Koski, W.P. Temple, A. Claremont, and D.R. Thomas Fifteen-year interval spirometric evaluation of the Oregon predictive equations Chest 92 1988 123 127 (Pubitemid 18037269)
55. R.O. Crapo, A.H. Morris, P.D. Clayton, and C.R. Nixon Lung volumes in healthy nonsmoking adults Bull Eur Physiopathol Respir 18 1982 419 425 (Pubitemid 12117075)
56. B. Burrows, J.E. Kasik, A.H. Niden, and W.R. Barclay Clinical usefulness of the single-breath pulmonary diffusing capacity test Am Rev Respir Dis 84 1961 789 806
57. W.A. Briscoe, and A.G. Dubois The relationship between airway resistance, airway conductance, and lung volumes in subjects of different age and body size J Clin Invest 37 1959 1279 1285
58. A.L. Hamilton, K.J. Killian, E. Summers, and N.L. Jones Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders Am J Respir Crit Care Med 152 1995 2021 2031
59. A.L. Ries Minimally clinically important difference for the UCSD Shortness of Breath Questionnaire, Borg Scale, and Visual Analog Scale COPD 2 2005 105 110 (Pubitemid 40776230)
60. S.P. Blackie, M.S. Fairbarn, and G.N. McElvaney Prediction of maximal oxygen uptake and power during cycle ergometry in subjects older than 55 years of age Am Rev Respir Dis 139 1989 1424 1429 (Pubitemid 19155501)
61. P.W. Davenport, and A. Vovk Cortical and subcortical central neural pathways in respiratory sensations Respir Physiol Neurobiol 167 2009 72 86
62. A. von Leuopoldt, and B. Dahme Cortical substrates for the perception of dyspnea Chest 128 2005 345 354 (Pubitemid 40994494)
63. M.M. Peters, K.A. Webb, and D.E. O'Donnell Combined physiological effects of bronchodilators and hyperoxia on exertional dyspnea in normoxic COPD Thorax 61 2006 559 567 (Pubitemid 44035134)
64. A. Somfay, S.M.L. Porzasz, and R. Casaburi Dose-response effect of oxygen on hyperinflation and exercise endurance in nonhypoxemic COPD patients Eur Respir J 18 2001 77 84 (Pubitemid 32717434)
65. D.E. O'Donnell, C. D'Arsigny, and K.A. Webb Effects of hyperoxia on ventilatory limitation during exercise in advanced COPD Am J Respir Crit Care Med 163 2001 892 898 (Pubitemid 32275860)
66. M.H. Worsley, A.D. Macleod, M.J. Brodie, A.J. Asbury, and C. Clark Inhaled fentanyl as a method of analgesia Anaesthesia 45 1990 449 451 (Pubitemid 20215821)
67. D.E. O'Donnell, T. Flüge, and F. Gerken Effects of tiotropium on lung hyperinflation, dyspnea and exercise tolerance in COPD Eur Respir J 23 2004 832 840 (Pubitemid 38807355)
68. D.E. O'Donnell, N. Voduc, M. Fitzpatrick, and K.A. Webb Effect of salmeterol on the ventilatory response to exercise in COPD Eur Respir J 24 2004 86 94 (Pubitemid 39029073)
69. T. Oga, K. Nishimura, and M. Tsukino A comparison of the effects of salbutamol and ipratropium bromide on exercise endurance in patients with COPD Chest 123 2003 1810 1816 (Pubitemid 36706698)
70. D.E. O'Donnell, R. Sanii, N.R. Anthonisen, and M. Younes Effect of dynamic airway compression on breathing pattern and respiratory sensation in severe chronic obstructive pulmonary disease Am Rev Respir Dis 135 1987 912 918 (Pubitemid 17055523)
71. R. Pellegrino, V. Brusasco, J.R. Rodarte, and T.G. Babb Expiratory flow limitation and regulation of end-expiratory lung volume during exercise J Appl Physiol 74 1993 2552 2558 (Pubitemid 23157088)
72. K.T.S. Pattinson, R.J. Governo, and B.J. MacIntosh Opioids depress cortical centers responsible for the volitional control of respiration J Neurosci 29 2009 8177 8186
73. K.T.S. Pattinson, R. Rogers, S.D. Mayhew, I. Tracey, and R.G. Wise Pharmacological FMRI: measuring opioid effects on the BOLD response to hypercapnia J Cereb Blood Flow Metab 27 2007 414 423 (Pubitemid 46148467)
74. M. Leppa, A. Korvenoja, and S. Carlson Acute opioid effects on human brain as revealed by functional magnetic resonance imaging Neuroimage 31 2006 661 669 (Pubitemid 43776689)